Arrivent Biopharma target price cut to $22 from $45
AVBP•JonesTrading cut its target price for Arrivent Biopharma to $22 from $45.
Related News
Marvell Technology, Inc.: Melius Research raises target price to $445 from $350
MRVL•
Capital One Financial target price cut to $285 from $300
COF•
Arqit Quantum CRO Paul Feenan reports sale of 506 shares worth $12,385.99
ARQQ•
Dollar holds losses as markets await Fed minutes, speakers
TLT•
Oil prices rise as storms and air strikes threaten supply
USO•